Dr. Song is a physician-scientist in the Division of Cardiovascular Medicine. His clinical interests include consultative and general cardiology with a particular interest in preventative cardiology and lipidology. He is board-certified in internal medicine, clinical lipidology, and board-eligible for cardiovascular medicine. He discovered and characterized two novel classes of oxidized bioactive lipids from omega-3 fatty acids, EPA, and DHA. He is currently funded by an NIH K08 grant studying the impact of dysfunctional HDL on platelet function and in vivo thrombosis. His research focus is on exploring the complex interplay of the bioactive lipids and lipoproteins such as HDL particles. Dr. Song also has interest in studying the protective mechanism of omega-3 fatty acids in the cardiovascular system, particularly in metabolic syndrome.
Wenliang Song, MD
Assistant Professor of Medicine, Department of Medicine
MD - Shandong University
MS, Translational Research - University of Pennsylvania, Philadelphia, Pennsylvania
Shandong University, 2004
Cardiovascular Medicine - Vanderbilt University Medical Center, 2019
Internal Medicine - Yale University, 2016